Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 13,291,167 $ 12,598,146
Short-term investments 33,051 32,358
Prepaid expenses and other current assets 5,587,238 988,641
Total current assets 18,911,456 13,619,145
Total assets 18,911,456 13,619,145
Current liabilities:    
Accounts payable 1,737,463 7,843,136
Accrued liabilities 480,962 1,506,526
Total current liabilities 2,218,425 9,349,662
Share-based compensation liability 199,263 422,002
Warrant liability 5,592 94,185
Total liabilities 2,423,280 9,865,849
Commitments and contingencies
Shareholders' equity:    
Common shares, no par value, unlimited shares authorized, 32,689,190 and 18,885,254 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively
Additional paid-in capital 107,546,433 97,590,426
Accumulated other comprehensive loss (371,184) (371,184)
Accumulated deficit (90,687,073) (93,465,946)
Total shareholders' equity 16,488,176 3,753,296
Total liabilities and shareholders' equity 18,911,456 13,619,145
Series 2 preferred shares    
Shareholders' equity:    
Convertible preferred stock